|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/05 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/352 | (2006.01) | ||
| A61K 31/352 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61K 31/05 | (2013.01) | ||
| A61K 36/185 | (2006.01) | ||
| A61K 36/185 | (2013.01) | ||
| A61K 31/658 | (2023.05) |
| (11) | Number of the document | 3710058 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18808075.8 |
| Date of filing the European patent application | 2018-11-15 | |
| (97) | Date of publication of the European application | 2020-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2018/053315 |
| Date | 2018-11-15 |
| (87) | Number | WO 2019/097238 |
| Date | 2019-05-23 |
| (30) | Number | Date | Country code |
| 201718862 | 2017-11-15 | GB |
| (72) |
GUY, Geoffrey , GB
KNAPPERTZ, Volker , GB
|
| (73) |
Jazz Pharmaceuticals Research UK Limited ,
Building 730 Kent Science Park, Sittingbourne Kent ME9 8AG,
GB
|
| (54) | USE OF CANNABIDIOL IN ADDITION TO LAMOTRIGINE FOR THE TREATMENT OF SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME |
| USE OF CANNABIDIOL IN ADDITION TO LAMOTRIGINE FOR THE TREATMENT OF SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME |